Stocks and Investing Stocks and Investing
Wed, August 10, 2022

Gregory Renza Maintained (ADCT) at Buy with Decreased Target to $29 on, Aug 10th, 2022


Published on 2024-10-27 22:35:19 - WOPRAI, Gregory Renza
  Print publication without navigation


Gregory Renza of RBC Capital, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $30 to $29 on, Aug 10th, 2022.

Gregory has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Gregory's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Gregory


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $44 on, Monday, July 11th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $17 on, Tuesday, May 10th, 2022
Contributing Sources